ALLMedicine™ Subdural Hematoma Center
Research & Reviews 1,217 results
https://doi.org/10.1016/j.clineuro.2023.107678
Clinical Neurology and Neurosurgery; Takei J, Inomata T et. al.
Mar 19th, 2023 - Approximately 10 % of patients with chronic subdural hematoma (CSDH) undergo reoperation after initial surgery. This study aimed to develop a predictive model for the recurrence of unilateral CSDH at initial surgery without hematoma volumetric ana...
https://doi.org/10.1007/s00381-023-05919-y
Child's Nervous System : ChNS : Official Journal of the I... Vasoya P, Raj V et. al.
Mar 19th, 2023 - It is very unusual for a primary intracranial malignancy to present as a chronic subdural hematoma. This case report describes one such case in a 3-year-old girl who presented with raised intracranial pressure following a mild head injury. Imaging...
https://doi.org/10.3171/2023.2.JNS222262
Journal of Neurosurgery; Sousa S, Pinto V et. al.
Mar 19th, 2023 - Timing of mobilization after chronic subdural hematoma (cSDH) surgery is highly heterogeneous among neurosurgical centers. Past studies have suggested that early mobilization may reduce medical complications without increasing recurrence, but evid...
https://doi.org/10.1016/j.injury.2023.03.014
Injury Shukla D, Konar S et. al.
Mar 19th, 2023 - We report results of a newly developed portable near-infrared spectroscopy (NIRS) based point-of-care device CEREBO® to detect traumatic intracranial hematoma (TICH). Patients with alleged history of head injury visiting emergency room were enroll...
https://doi.org/10.1227/neu.0000000000002365
Neurosurgery Sattari SA, Yang W et. al.
Mar 18th, 2023 - The results from studies that compare middle meningeal artery (MMA) embolization vs conventional management for patients with chronic subdural hematoma are varied. To conduct a systematic review and meta-analysis on studies that compared MMA embol...
Drugs 3 results see all →
Clinicaltrials.gov 84 results
https://clinicaltrials.gov/ct2/show/NCT03905031
Mar 6th, 2023 - Patients that present to Dayton Children's Hospital with a head CT order for suspected TBI will be approached for enrollment. An alert will notify study personnel as CT scans are ordered. The goal is to obtain NIRS data within four-hours before or...
https://clinicaltrials.gov/ct2/show/NCT04170582
Mar 2nd, 2023 - Chronic subdural hematoma (cSDH) is a frequent disease in- predominantly - elderly patients often caused by minor trauma to the bridging veins eventually leading to a collection of old blood in the subdural space over time. Besides age of the pati...
https://clinicaltrials.gov/ct2/show/NCT04573387
Feb 21st, 2023 - Chronic subdural hematomas (CSDHs) are one of the most common neurosurgical conditions. The goal of surgery is to alleviate symptoms and minimize the risk of symptomatic recurrences. The standard surgical technique includes burr-hole craniostomy, ...
https://clinicaltrials.gov/ct2/show/NCT05713630
Feb 17th, 2023 - Subdural hematoma (SDH) is a common condition experienced after head injury. Blood collects on the surface of the brain, causing headaches which can progress to confusion, weakness, or even coma. While patients with SDH often receive surgery, not ...
https://clinicaltrials.gov/ct2/show/NCT05599217
Feb 8th, 2023 - Chronic subdural hematoma (CSDH) is one of the most common neurosurgical conditions, which is considered to be an inflammatory disease. Dietary factors can have an impact on the inflammatory mechanism in human body, which can increase a variety of...
News 84 results
https://www.medscape.com/viewarticle/984462
Nov 22nd, 2022 - Using irrigation warmed to body temperature during burr hole evacuation for chronic subdural hematoma (cSDH) cuts the risk for recurrence by more than half compared and should become the standard of care, new research suggests. Results from the mu...
https://www.onclive.com/view/bcma-and-cd3-t-cell-engaging-bispecific-antibody-shows-promise-in-r-r-multiple-myeloma
Nov 1st, 2022 - ABBV-383 was effective and well tolerated at all administered doses in patients with relapsed/refractory multiple myeloma, according to safety and efficacy results from an ongoing first-in-human, phase 1 dose-escalation/-expansion study (NCT039337...
https://www.onclive.com/view/cediranib-plus-olaparib-elicits-rpfs-benefit-in-metastatic-castration-resistant-prostate-cancer
Oct 24th, 2022 - The combination of cediranib and olaparib (Lynparza) significantly improved radiographic progression-free survival (rPFS) compared with olaparib monotherapy in patients with metastatic castration-resistant prostate cancer (mCRPC), according to fin...
https://www.onclive.com/view/bispecific-antibody-abbv-383-looks-to-fill-unmet-need-in-heavily-pretreated-multiple-myeloma
Aug 28th, 2022 - Promising safety and efficacy results were observed with the novel bispecific antibody ABBV-383 in patients with heavily pretreated relapsed or refractory multiple myeloma, according to updated results from a phase 1 trial (NCT03933735) presented ...
https://www.mdedge.com/familymedicine/article/255453/preventive-care/helping-patients-move-forward-following-traumatic
MDedge Family Medicine; Elizabeth A. Imbesi, PhD, ABPP
Jun 15th, 2022 - THE CASE Declan M*, a 42-year-old man, presents as a new patient for general medical care. One year ago, he sustained a severe frontal traumatic brain injury (TBI) when he was hit by a car while crossing a street.